| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -4.81M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AKTX returned -78.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -32.1% |
| 1 year | -78.7% |
| 5 years | -99.5% |
| 10 years | -99.9% |
| All-time high | $71,200.00 (Jan 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AKTX would be worth today ›No. Akari Therapeutics, Plc has not paid a dividend in the past 12 months.
Akari Therapeutics, Plc stock trades on NASDAQ under the ticker symbol AKTX.
Akari Therapeutics, Plc is part of the Healthcare sector.
Akari Therapeutics, Plc has a market cap of 15.28M USD, based on the latest quote.
